PSYC Expands its Reach with the Launch of Social Media Platforms
July 16, 2020 08:30 ET
|
Global Trac Solutions, Inc.
LAS VEGAS, July 16, 2020 (GLOBE NEWSWIRE) -- Global Trac Solutions, Inc. (OTCPink: PSYC) (“Global” “PSYC” or the “Company”) is pleased to announce that the Company’s new social media channels are...
Jounce Therapeutics Announces Update on Strategic Collaboration with Celgene Corporation
July 23, 2019 16:00 ET
|
Jounce Therapeutics, Inc.
- Celgene licenses JTX-8064, resulting in $50.0 million upfront payment to Jounce - - Jounce retains full worldwide rights to vopratelimab, JTX‑4014 and all discovery programs - - Company to host...
Voyager Therapeutics Announces Restructured Gene Therapy Relationship with Sanofi Genzyme and Portfolio Update
June 17, 2019 07:30 ET
|
Voyager Therapeutics, Inc.
Gains worldwide rights to VY-HTT01 for Huntington’s disease Resources to be reallocated to VY-HTT01 and other programs; intends to seek a partner for the SOD1 ALS program CAMBRIDGE, Mass., June 17,...
One Step Vending, Corp. Announces Strategic Collaboration with Acqua Cannabis LLC
February 04, 2019 09:30 ET
|
One Step Vending Corp.
HARRISON, NY, Feb. 04, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – One Step Vending, Corp. announces entering into an agreement with Acqua Cannabis LLC., a CBD infused products supplier, for the...
Neurocrine Biosciences and Voyager Therapeutics Form Strategic Development and Commercialization Collaboration for Parkinson’s Disease and Friedreich’s Ataxia
January 29, 2019 07:00 ET
|
Voyager Therapeutics, Inc.; Neurocrine Biosciences, Inc.
Collaboration leverages strengths and efforts of both companies towards developing and commercializing life-changing treatments for severe neurological diseases Neurocrine Biosciences gains...